University of Liverpool Repository

Number of items: 40.

Boyland, Emma ORCID: 0000-0001-8384-4994, McGale, Lauren, Maden, Michelle ORCID: 0000-0003-4419-6343, Hounsome, Juliet, Boland, Angela ORCID: 0000-0002-5435-8644, Angus, Kathryn and Jones, Andrew (2022) Association of Food and Nonalcoholic Beverage Marketing With Children and Adolescents' Eating Behaviors and Health A Systematic Review and Meta-analysis. JAMA PEDIATRICS, 176 (7). e221037-.

Collapse authors list.
Aslam, RW ORCID: 0000-0002-0916-9641, Bates, V, Dundar, Yenal, Hounsome, Juliet ORCID: 0000-0002-2026-3778, Richardson, Marty ORCID: 0000-0002-7097-8704, Krishan, Ashma, Dickson, Rumona ORCID: 0000-0003-1416-0913, Boland, Angela ORCID: 0000-0002-5435-8644, Kotas, Eleanor, Fisher, Joanne et al (show 2 more authors) , Sikdar, Sudip and Robinson, Louise (2016) Automated tests for diagnosing and monitoring cognitive impairment: a diagnostic accuracy review. Health Technology Assessment, 20 (77). 1-+.

Stainthorpe, Angela, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Dundar, Yenal, McEntee, Joanne and Syndikus, Isabel (2020) Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 4 (4). pp. 563-574.

Fleeman, Nigel ORCID: 0000-0002-4637-9779, Stainthorpe, Angela, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty ORCID: 0000-0002-7097-8704, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie, Dundar, Yenal, Kotas, Eleanor, McEntee, Joanne and Isabel, Syndikus (2018) Brentuximab vedotin for treating relapsed or refractory CD30-positive cutaneous T-cell lymphoma (17/56/12). [Report]

Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Duarte, Rui, Boland, Angela ORCID: 0000-0002-5435-8644, Kotas, Eleanor, Dundar, Yenal, McEntee, Joanne and Ahmad, Sajjad (2019) Cenegermin for Treating Neurotrophic Keratitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 3 (4). pp. 453-461.

Lambe, Tosin ORCID: 0000-0002-6229-2454, Duarte, Rui, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Kotas, Eleanor, McEntee, Joanne and Pomeroy, Ian (2019) Cladribine Tablets for the First-Line Treatment of Relapsing-Remitting Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS, 37 (3). pp. 345-357.

Duarte, Rui, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie, Kotas, Eleanor and Mcentee, Joanne (2017) Cladribine for the treatment of relapsing-remitting multiple sclerosis. [Report]

Pilkington, Gerlinde ORCID: 0000-0003-0028-0746, Boland, Angela ORCID: 0000-0002-5435-8644 and Dickson, Rumona ORCID: 0000-0003-1416-0913 (2017) Comprehensive geriatric assessment for older people with cancer. Cancer Nursing Practice, 16 (1). pp. 25-30.

Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dickson, Rumona ORCID: 0000-0003-1416-0913, Dwan, Kerry, Richardson, Marty ORCID: 0000-0002-7097-8704, Dundar, Yenal, Davis, Helen and Banks, Lindsay (2015) Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group Perspective. PHARMACOECONOMICS, 33 (9). pp. 893-904.

Collapse authors list.
Dickson, Rumona ORCID: 0000-0003-1416-0913, Boland, Angela ORCID: 0000-0002-5435-8644, Duarte, Rui, Kotas, Eleanor, Woolacott, Nerys, Hodgson, Robert, Riemsma, Rob, Grimm, Sabine, Ramaekers, Bram, Joore, Manuela et al (show 9 more authors) (2018) EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 16 (4). pp. 429-432.

Houten, Rachel ORCID: 0000-0002-4315-7732, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Lambe, Tosin ORCID: 0000-0002-6229-2454, Dundar, Yenal, Kotas, Eleanor and McEntee, Joanne (2021) Encorafenib with Binimetinib for the Treatment of Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 5 (1). pp. 13-22.

Collapse authors list.
Hyseni, Lirije, Guzman-Castillo, Maria, Kypridemos, Chris ORCID: 0000-0002-0746-9229, Collins, Brendan ORCID: 0000-0002-3023-8189, Schwaller, Ellen ORCID: 0000-0002-2769-0449, Capewell, Simon ORCID: 0000-0003-3960-8999, Boland, Angela ORCID: 0000-0002-5435-8644, Dickson, Rumona ORCID: 0000-0003-1416-0913, O'Flaherty, Martin ORCID: 0000-0001-8944-4131, Gallacher, Kay et al (show 2 more authors) , Hale, Peter and Lloyd-Williams, Ffion (2020) Engaging with stakeholders to inform the development of a decision-support tool for the NHS health check programme: qualitative study. BMC HEALTH SERVICES RESEARCH, 20 (1). 394-.

Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Duarte, Rui, Richardson, Marty ORCID: 0000-0002-7097-8704, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Boland, Angela ORCID: 0000-0002-5435-8644, Kotas, Eleanor, McEntee, Joanne and Thorp, Nicky (2019) Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 3 (3). pp. 293-302.

Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Duarte, Rui, Chaplin, Marty ORCID: 0000-0002-7097-8704, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Boland, Angela ORCID: 0000-0002-5435-8644, Kotas, Eleanor, Mcentee, Joanne and Thorp, Nicky (2017) Eribulin for treating locally advanced or metastatic breast cancer after one prior chemotherapy regimen. [Report]

Collapse authors list.
Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Bagust, Adrian ORCID: 0000-0002-2142-5767, Boland, Angela ORCID: 0000-0002-5435-8644, Dwan, Kerry, Beale, Sophie ORCID: 0000-0003-0164-103X, Hockenhull, Juliet ORCID: 0000-0002-2026-3778, Proudlove, Christine, Dundar, Yenal, Richardson, Marty ORCID: 0000-0002-7097-8704, Dickson, Rumona ORCID: 0000-0003-1416-0913 et al (show 2 more authors) , Mullard, Anna and Marshall, Ernie (2015) Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 19 (47). I-133.

Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Boland, Angela ORCID: 0000-0002-5435-8644, Bates, Victoria, Vecchio, Fabio, Dundar, Yenal, Chaplin, Marty ORCID: 0000-0002-7097-8704 and Green, John A (2021) First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 3 (3). CD010383-.

Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Dwan, Kerry, Boland, Angela ORCID: 0000-0002-5435-8644, Bates, Victoria, Vecchio, Fabio, Dundar, Yenal, Jain, Pooja and Green, John A (2016) First‐line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non‐squamous non‐small cell lung cancer. Cochrane Database of Systematic Reviews, 2016 (5). CD010383-.

Collins, Brendan ORCID: 0000-0002-3023-8189, Kypridemos, C ORCID: 0000-0002-0746-9229, Lloyd-Williams, Ffion, Dickson, Rumona ORCID: 0000-0003-1416-0913, Boland, Angela ORCID: 0000-0002-5435-8644, Buchan, Iain, Couch, Philip, Capewell, Simon ORCID: 0000-0003-3960-8999 and O'Flaherty, ME ORCID: 0000-0001-8944-4131 (2017) How do we get the best outcomes from NHS Health Checks? workHORSE: an NIHR-funded Health Technology Assessment of the NHS Health Checks Programme. In: Getting serious about prevention 2018, 2018-2-8 - 2018-2-8, London, UK.

Haque, Afzal (2020) How should root filled posterior teeth be restored? A systematic review and survey to general dental practitioners. Doctor of Dental Science thesis, University of Liverpool.

Collapse authors list.
Duarte, Rui, Stainthorpe, Angela, Mahon, James, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Richardson, Marty ORCID: 0000-0002-7097-8704, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Kotas, Eleanor, Boland, Angela ORCID: 0000-0002-5435-8644, Thom, Howard, Marshall, Tom et al (show 2 more authors) , Hall, Mark and Takwoingi, Yemisi (2019) Lead-I ECG for detecting atrial fibrillation in patients attending primary care with an irregular pulse using single-time point testing: A systematic review and economic evaluation. PLOS ONE, 14 (12). e0226671-.

Collapse authors list.
Duarte, Rui, Stainthorpe, Angela ORCID: 0000-0002-2531-9371, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Richardson, Marty ORCID: 0000-0002-7097-8704, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Mahon, James, Kotas, Eleanor, Boland, Angela ORCID: 0000-0002-5435-8644, Thom, Howard, Marshall, Tom et al (show 2 more authors) , Hall, Mark and Takwoingi, Yemisi (2020) Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 24 (3). 1-+.

Collapse authors list.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Bagust, Adrian ORCID: 0000-0002-2142-5767, Richardson, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Hounsome, Juliet ORCID: 0000-0002-2026-3778, Duarte, Rui et al (show 1 more authors) and Shenoy, Aditya (2020) Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 24 (2). 1-+.

O'Flaherty, Martin ORCID: 0000-0001-8944-4131, Lloyd-Williams, Ffion, Capewell, Simon ORCID: 0000-0003-3960-8999, Boland, Angela ORCID: 0000-0002-5435-8644, Maden, Michelle ORCID: 0000-0003-4419-6343, Collins, Brendan ORCID: 0000-0002-3023-8189, Bandosz, Piotr, Hyseni, Lirije and Kypridemos, Chris ORCID: 0000-0002-0746-9229 (2021) Modelling tool to support decision-making in the NHS Health Check programme: workshops, systematic review and co-production with users. HEALTH TECHNOLOGY ASSESSMENT, 25 (35). 1-+.

Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Boland, Angela ORCID: 0000-0002-5435-8644, Dwan, Kerry, Chaplin, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie, Kotas, Eleanor, Banks, Lindsay and Greystoke, Alastair (2014) Nintedanib for previously treated locally advanced or metastatic non small cell lung cancer. [Report]

Collapse authors list.
Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Nevitt, Sarah, Bresnahan, Rebecca, Boland, Angela, Beale, Sophie, Lambe, Tosin, Bhattacharyya, Devarshi, Dundar, Yenal, McEntee, Joanne et al (show 1 more authors) and Boon, Cheng (2021) Nivolumab in combination with chemotherapy for untreated advanced gastric, gastro-oesophageal junction, or oesophageal adenocarcinoma [ID1465]. [Report]

Chaplin, Marty ORCID: 0000-0002-7097-8704, Bresnahan, Rebecca, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Houten, Rachel ORCID: 0000-0002-4315-7732, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Marsden, Ashley and Munot, Pinki (2023) Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15. PharmacoEconomics - Open.

Stainthorpe, Angela ORCID: 0000-0002-2531-9371, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Bagust, Adrian ORCID: 0000-0002-2142-5767, Richardson, Marty ORCID: 0000-0002-7097-8704, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Duarte, Rui, Kotas, Eleanor, Banks, Lindsay and Palmer, Daniel ORCID: 0000-0002-7147-5703 (2018) Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 36 (10). pp. 1153-1163.

Collapse authors list.
Bresnahan, Rebecca, Houten, Rachel ORCID: 0000-0002-4315-7732, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Mahon, James, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Bhattacharyya, Devarshi, Dundar, Yenal, McEntee, Joanne et al (show 3 more authors) (2023) Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics - open, 7 (4). pp. 525-536.

Fleeman, Nigel ORCID: 0000-0002-4637-9779, Abdulla, Ahmed, Bagust, Adrian ORCID: 0000-0002-2142-5767, Beale, Sophie ORCID: 0000-0003-0164-103X, Richardson, Marty ORCID: 0000-0002-7097-8704, Stainthorpe, Angela ORCID: 0000-0002-2531-9371, Boland, Angela ORCID: 0000-0002-5435-8644, Kotas, Eleanor, McEntee, Joanne and Palmer, Daniel ORCID: 0000-0002-7147-5703 (2018) Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS, 36 (3). pp. 289-299.

Hounsome, Juliet ORCID: 0000-0002-2026-3778, Pilkington, Gerlinde ORCID: 0000-0003-0028-0746, Mahon, James, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Kotas, Eleanor, Renton, Tara and Dickson, Rumona ORCID: 0000-0003-1416-0913 (2020) Prophylactic removal of impacted mandibular third molars: a systematic review and economic evaluation. Health Technology Assessment, 24 (30). 1-+.

Boyland, Emma ORCID: 0000-0001-8384-4994, McGale, Lauren, Maden, Michelle ORCID: 0000-0003-4419-6343, Hounsome, Juliet ORCID: 0000-0002-2026-3778, Boland, Angela ORCID: 0000-0002-5435-8644 and Jones, Andrew (2022) Systematic review of the effect of policies to restrict the marketing of foods and non-alcoholic beverages to which children are exposed. OBESITY REVIEWS, 23 (8). e13447-.

Collapse authors list.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Richardson, Marty ORCID: 0000-0002-7097-8704, Krishan, Ashma, Stainthorpe, Angela ORCID: 0000-0002-2531-9371, Abdulla, Ahmed, Kotas, Eleanor, Banks, Lindsay et al (show 1 more authors) and Payne, Miranda (2017) Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS, 35 (10). pp. 1035-1046.

Collapse authors list.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie, Chaplin, Marty ORCID: 0000-0002-7097-8704, Krishan, Ashma, Stainthorpe, Angela, Abdulla, Ahmed, Kotas, Eleanor, Banks, Lindsay et al (show 1 more authors) and Payne, Miranda (2016) Talimogene laherparepvec for treating metastatic melanoma. [Report]

Collapse authors list.
Houten, Rachel ORCID: 0000-0002-4315-7732, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Chaplin, Marty, Edwards, Katherine, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Marsden, Ashley, Malik, Zafar et al (show 1 more authors) (2023) Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 7 (3). pp. 345-358.

Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Houten, Rachel, Edwards, Katherine, Donegan, Sarah, Boland, Angela, Beale, Sophie, Dundar, Yenal and Mcentee, Joanne (2023) Upadacitinib for treating moderately to severely active ulcerative colitis [ID3953]. [Report]